Irisin and chemerin levels in patients with Type 2 diabetes mellitus

References (9)

1. American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care, 2017; 40: S11-S24
2. International Diabetes Federation. IDF Diabetes Atlas Eighth edition, Brussels: International Diabetes Federation, 2017
3. Kocot J, Dziemidok P, Kielczykowska M, Hordyjewska A, Szczesniak G, Musik I. Adipokine profile in Patients with Type 2 Diabetes Depends on Degree of Obesity. Med Sci Monit, 2017; 23: 4995-5004
4. Banerjee A, Khemka VK, Roy D, Poddar J, Roy TKS, Karnam SA. Role of Serum Adiponectin and Vitamin D in Prediabetes and Diabetes Mellitus. Can J Diabetes, 2017; 41: 259-265
5. Han J, Kim SH, Suh YJ, Lim HA, Shin H, Cho SG, et al. Serum Chemerin Levels are Associated with Abdominal Visceral Fat in Type 2 Diabetes. J Korean Med Sci, 2016; 31: 924-931
6. Shanaki M, Moradi N, Emamgholipour S, Fadaei R, Poustchi H. Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes. Diabetes Metab Syndr, 2017; Suppl 1: S467-S472
7. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1- alpha-dependent myokine that drives brown-fat-likedevelopment of white fat and thermogenesis. Nature, 2012; 481: 463-8
8. Wittamer V, Gre´goire F, Robberecht P, Vassart G, Communi D, Parmentier M. The C-terminal Nonapeptide of Mature Chemerin Activates the Chemerin Receptor with Low Nanomolar Potency. J Biol Chem, 2004; 279: 9956-62
9. Helfer G, Wu QF. Chemerin: a multifaceted adipokine involved in metabolic disorders. J Endocrinol, 2018; 238(2): R79-R94. 10.Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem, 2007; 282; 38: 28175-88. 11.Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jovett J, Collier G, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology, 2007; 148: 4687-94. 12.Buechler C, Feder S, Haberl EM, Aslanidis C. Chemerin Isoforms and Activity in Obesity. Int J Mol Sci, 2019; 20(5): 1128. 13.Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: a renaissance in metabolism? Metabolism, 2013; 62: 1037-44. 14.Aldhahi W, Hamdy O. Adipokines, inflammation, and the endotelium in diabetes. Curr Diab Rep, 2003; 3(4): 293-8 15.Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F, et al. Adipokines: biofactors from white adipose tissue. A Complex hub among inflammation, metabolism, and immunity. Bio Factors, 2011; 37: 413-20. 16.Ou